CardiovascularMFT Profile
CardiovascularMFT

@CVD_MFT

Followers
29
Following
0
Media
21
Statuses
58

Clinical research team led by Professor Soran Cardiovascular Disease, Obesity, Lipoprotein and Diabetes Research in Manchester, UK

Manchester, UK
Joined July 2023
Don't wanna be here? Send us removal request.
@ShivaniM_KC
Shivani Misra
@ShivaniM_KC
3 months
Thrilled to finally share what has kept me occupied these past few months; our @TheLancet Series on early-onset type 2 diabetes is out! Has been an honour to be the Lead Author for this Series brining together global experts; thanks @callam_editor for inviting me People
Tweet media one
Tweet media two
Tweet media three
Tweet media four
18
78
290
@maria_bergami
Maria Bergami, MD, PhD
@maria_bergami
6 months
Which type of #MCS to choose? When to stop 🛑? How to manage #bleedingrisk 🩸and #thrombotic complications? This and much more at #ACVC2025!
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
6
14
@NWEndoDiabUK
North-West Deanery Endo-Diab Training Programme
@NWEndoDiabUK
9 months
@CVD_MFT NW Greater Manchester Endodiab Trainees at Lipid Forum 10/12/2024
Tweet media one
0
3
6
@CVD_MFT
CardiovascularMFT
@CVD_MFT
9 months
A wonderful presentation by @FerdousiMaryam on 'Is Neuropathy Part of FCS Disease Burden?' #Neuropathy #Lipid #FCS #NeuroDiabLipid
Tweet media one
0
2
2
@CVD_MFT
CardiovascularMFT
@CVD_MFT
9 months
Professor Soran with the opening remarks for Day 2 of the Lipid Forum
Tweet media one
0
0
0
@CVD_MFT
CardiovascularMFT
@CVD_MFT
9 months
A wonderful and engaging first day of the 14th Lipid Forum. Superb speakers and presentations, we're a excited for Day 2, tomorrow! #EndoDiabLipid #Lipids #Diabetes #Education #Learning #Presentations #Forum https://t.co/OXHZHaeaOM
Tweet media one
0
1
2
@CVD_MFT
CardiovascularMFT
@CVD_MFT
9 months
Professor Dev Datta is presenting his work on 'New Therapies and Future of Lipoprotein Apheresis in the Management of HoFH' #Lipids #FH #HoFH
Tweet media one
0
1
0
@CVD_MFT
CardiovascularMFT
@CVD_MFT
9 months
Professor Soran with the Opening Remarks for the 14th Lipid and Atherosclerosis Forum: Utilising Recent Advances to Identify and Address Unmet Clinical Needs
Tweet media one
0
1
0
@Neurodiab_eu
Neurodiab
@Neurodiab_eu
10 months
In the occasion of the 150th Publication News NEUROdiab thanks the Members of the Discovery Team of Publication News ( https://t.co/MzPNwX4tuX)
Tweet media one
0
4
8
@drbilalbashir
Bilal Bashir
@drbilalbashir
1 year
FCS leads to small fibre nerve damage, clinical neuropathy & early CAN @Neurodiab_eu @heartukcharity @CVD_MFT @RareDiseases @CheckOrphan
Tweet media one
Tweet media two
Tweet media three
0
5
13
@drbilalbashir
Bilal Bashir
@drbilalbashir
1 year
Hypertriglyceridaemia in absence of diabetes causes peripheral & cardiac autonomic neuropathy. @Neurodiab_eu @heartukcharity @OfficialUoM @CVD_MFT @MFT_Research
Tweet media one
0
3
7
@drbilalbashir
Bilal Bashir
@drbilalbashir
11 months
Our latest article from UK FCS National Registry has been chosen as one of the two “Featured” articles in the November 2024 issue of @atvbahajournals https://t.co/nf5Oi8vWH9
Tweet card summary image
ahajournals.org
BACKGROUND: Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disorder. This study aimed to study the genotype distribution of FCS-causing genes in the United Kingdom, genotype-...
1
3
9
@CVD_MFT
CardiovascularMFT
@CVD_MFT
1 year
The 2nd talk by @drbilalbashir was on 'Hypertriglyceridaemia and Cardiovascular Autonomic Function in Patients Without Diabete Mellitus'
Tweet media one
0
1
5
@CVD_MFT
CardiovascularMFT
@CVD_MFT
1 year
The first talk was by @drbilalbashir who presented his talk 'Genetic Landscape of Familial Chylomicronaemia Syndrome (FCS) and Multifactorial Chylomicronaemia Syndrome (MCS) in the UK
Tweet media one
0
1
4
@CVD_MFT
CardiovascularMFT
@CVD_MFT
1 year
Our team have been busy presenting at @heartukcharity conference this week #lipids #heartuk #neuropathy #diabetes #triglycerides
Tweet media one
0
0
4
@heartukcharity
HEART UK
@heartukcharity
1 year
And concluding the Primary & Healthcare Oral Abstracts is Dr Raabya Pasha, (Manchester UK) presenting Clinical service quality and unmet needs in Homozygous Familial Hypercholesterolaemia Patients: Insights from UK tertiary centres. #hukconf #lipids
Tweet media one
0
1
1
@heartukcharity
HEART UK
@heartukcharity
1 year
Into our oral abstract sessions starting with Dr Bilal Bashir (Manchester UK) in Medical & Scientific on Genetic Landscape of Familial Chlomicronaemia Syndrome (FCS) and Multifactorial Chlomicronaemia Syndrome (MCS) in United Kingdom. #hukconf #lipids
Tweet media one
0
2
4
@heartukcharity
HEART UK
@heartukcharity
1 year
Dr Bilal Bashir, (Manchester UK) now presenting in the Primary & Healthcare oral abstracts Hypertriglyceridaemia & Cardiovascular Autonomic Function in Patients without Diabetes Mellitus #hukconf #lipids
Tweet media one
0
2
2
@drbilalbashir
Bilal Bashir
@drbilalbashir
1 year
Cardiovascular and Lipid research team at #hukconf #lipids @heartukcharity @CVD_MFT @MFT_Research
Tweet media one
0
4
13
@drbilalbashir
Bilal Bashir
@drbilalbashir
2 years
We validate the "FCS Score" in a large cohort of ethnically and genotypically diverse population from UK. @heartukcharity @CVD_MFT @manchester_cv @OfficialUoM @EASCongress https://t.co/n1a47jsUrG
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
Our study validates the FCS score in the UK population to distinguish FCS from MCS. While additional FCS predictors were identified, they did not improve further the score diagnostic performance.
0
4
6